Showing results (1431-1440 of 1,566) with videos related to
Sort By:
Pageof 157
NPJ Breast Cancer|June 2, 2023
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort studyOfer Rotem, Idit Peretz, Michelle Leviov, et al.European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.Acta Ophthalmologica|March 28, 2022
Prevalence and determinants of reticular pseudodrusen in the Russian Ural Eye and Medical StudyMukharram M Bikbov, Gyulli M Kazakbaeva, Ellina M Rakhimova, et al.Bioorganic & Medicinal Chemistry Letters|March 11, 2021
New class of hantaan virus inhibitors based on conjugation of the isoindole fragment to (+)-camphor or (-)-fenchone hydrazonesvOlga I Yarovaya, Kseniya S Kovaleva, Anna A Zaykovskaya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1Giorgio V Scagliotti, Ihor Vynnychenko, Keunchil Park, et al.Carcinogenesis|January 31, 2012
Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesisSophia P Karabela, Ioannis Psallidas, Taylor P Sherrill, et al.The American Journal of Pathology|May 17, 2016
Epithelial-Derived Inflammation Disrupts Elastin Assembly and Alters Saccular Stage Lung DevelopmentJohn T Benjamin, Riet van der Meer, Amanda M Im, et al.Viruses|June 24, 2022
Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 VirusesOlga I Yarovaya, Dmitriy N Shcherbakov, Sophia S Borisevich, et al.Molecular Cancer Therapeutics|January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responsesVinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.Cancer|November 30, 2018
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriersYael Laitman, Rachel Michaelson-Cohen, Einat Levi, et al.Pageof 157